Position in DYN
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$183,439
New position
Shares Held
10,118
first reported quarter
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 100%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026STEPHENS INC /AR/ holds $5,456,488 across 11 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,900 | $1,440,517 | |
| 2 | TECH |
BIO-TECHNE Corp
|
12,036 | $850,343 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
831 | $518,161 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
1,625 | $513,646 | |
| 5 | EXEL |
Exelixis, Inc.
|
9,079 | $493,988 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,638 | $493,087 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
4,954 | $387,749 | |
| 8 | ARGX |
Argenx SE
|
325 | $301,525 |
All Filings in DYN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $183,439 | 10,118 | Shares | Defined | 2026-04-28 | |
| No filing history on record for this holder in this stock. | ||||||